An announcement from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Ltd. has announced a board meeting scheduled for March 26, 2025, to discuss several key financial and operational matters. The agenda includes the approval of the audited consolidated financial statements for 2024, the draft announcement of these results, and considerations regarding a final dividend and the upcoming annual general meeting. This meeting is crucial for stakeholders as it will outline the company’s financial health and strategic decisions moving forward.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with a market presence on the Hong Kong Stock Exchange.
YTD Price Performance: -15.05%
Average Trading Volume: 3,943
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €772.5M
See more data about 1681 stock on TipRanks’ Stock Analysis page.